Application of the Immunoscore as prognostic tool for hepatocellular carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of the Immunoscore as prognostic tool for hepatocellular carcinoma
Authors
Keywords
Hepatocellular carcinoma, TNM Stage, Immunoscore, Tumor-infiltrating lymphocytes, Programmed Death Ligand 1 (PD-L1)
Journal
Journal for ImmunoTherapy of Cancer
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-03
DOI
10.1186/s40425-016-0182-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
- (2016) Junzo Hamanishi et al. International Journal of Clinical Oncology
- Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
- (2016) A. Gabrielson et al. Cancer Immunology Research
- Cellular prognostic markers in hepatocellular carcinoma
- (2015) Luigi Buonaguro et al. Future Oncology
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: A comprehensive and evidence-based comparison and review
- (2014) Zhi Ven Fong et al. CANCER
- Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
- (2014) M.-G. Anitei et al. CLINICAL CANCER RESEARCH
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Staging systems of hepatocellular carcinoma: A review of literature
- (2014) Marcello Maida WORLD JOURNAL OF GASTROENTEROLOGY
- Serum Insulin-like Growth Factor-I Level Is an Independent Predictor of Recurrence and Survival in Early Hepatocellular Carcinoma: A Prospective Cohort Study
- (2013) E. J. Cho et al. CLINICAL CANCER RESEARCH
- Challenges in cancer vaccine development for hepatocellular carcinoma
- (2013) Luigi Buonaguro et al. JOURNAL OF HEPATOLOGY
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
- (2012) Qiujin Shen et al. LANCET ONCOLOGY
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Evaluation of the seventh edition of the American Joint Committee on Cancer tumour–node–metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system
- (2012) Albert C.Y. Chan et al. HPB
- Identification of osteopontin as a novel marker for early hepatocellular carcinoma
- (2011) Sufen Shang et al. HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started